Befejeződött1. fázis
Phase I, first-in-man, randomised, placebo-controlled, single dose escalation study to investigate the effects of LPH-5 on safety, tolerability, pharmacokinetic and pharmacodynamic parameters in healthy participants
Key facts
- Where
- Rennes, FranciaországSee the site
- Phase
- 1. fázis
Where in Franciaország
- BiotrialRennes, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lophora ApS
- Trial code
- EU 2024-512330-15-00
- Record updated
- 2025. augusztus 1.